Pathogenicity and diagnostic methods of human cytomegalovirus

Eric Tzyy Jiann Chong; Aziera Farhanah Adihidayah Suardi; Ping-Chin Lee

doi:10.51200/bijb.v3i.4073

Authors

Eric Tzyy Jiann Chong
Aziera Farhanah Adihidayah Suardi
Ping-Chin Lee

DOI:

https://doi.org/10.51200/bijb.v3i.4073

Keywords:

diagnostic methods, human cytomegalovirus, infectious diseases, pathogenicity

Abstract

Human cytomegalovirus (HCMV) is a beta-herpesvirus capable of establishing lifelong infection in humans. It is primarily transmitted through bodily fluids like blood, urine, and saliva. In healthy individuals, primary HCMV infections are often asymptomatic but can lead to persistent or latent infections. However, immunocompromised individuals such as organ transplant recipients and those with acquired immunodeficiency syndrome, are at risk of severe and potentially fatal illnesses resulting from HCMV pathogenicity. Consequently, it is crucial to gain a comprehensive understanding of HCMV’s pathogenicity and diagnostic methods, particularly for detecting the presence of HCMV in individuals with compromised immune systems. This review aims to address these aspects and provide insights to assist relevant authorities in designing effective interventions and managing HCMV-related illnesses.

Author Biographies

Eric Tzyy Jiann Chong

Biotechnology Research Institute,
Jalan UMS, Universiti Malaysia Sabah,
88400 Kota Kinabalu, Sabah, Malaysia

Aziera Farhanah Adihidayah Suardi

Faculty of Science and Natural Resources,
Jalan UMS, Universiti Malaysia Sabah,
88400 Kota Kinabalu, Sabah, Malaysia

Ping-Chin Lee

Biotechnology Research Institute,
Jalan UMS, Universiti Malaysia Sabah,
88400 Kota Kinabalu, Sabah, Malaysia

Faculty of Science and Natural Resources,
Jalan UMS, Universiti Malaysia Sabah,
88400 Kota Kinabalu, Sabah, Malaysia

References

Abu-Nader, R., & Patel, R. (2000). Current management strategies for the treatment and prevention of cytomegalovirus infection in solid organ transplant recipients. BioDrugs, 13, 159 – 175.

Ali, M.K., Shia, J.S., & Al-Marsome, H.D. (2019). Detection of HSV and CMV in pregnant and miscarriage women by ELISA and real time PCR assay. Research Journal of Pharmacy and Technology, 12 (9), 4090 - 4094.

Bhat, V., Joshi, A., Sarode, R., & Chavan, P. (2015). Cytomegalovirus infection in the bone marrow transplant patient. World Journal of Transplantation, 5 (4), 287 – 291.

Blok, M.J., Lautenschlager, I., Goossens, V.J., Middeldorp, J.M., Vink, C., Hockerstedt, K., & Bruggeman, C.A. (2000). Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification. Journal of Clinical Microbiology, 38 (12), 4485 – 4491.

Cannavan, F.P.S., Costallat, L.T.L., Bértolo, M.B., Rossi, C.L., & Costa, S.C.B. (1998). False positive IgM antibody tests for human cytomegalovirus (HCMV) in patients with SLE. Lupus, 7, 61 – 62.

Cannon, M.J., Schmid, D.S., & Hyde, T.B. (2010). Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Reviews in Medical Virology, 20 (4), 202 - 213.

Carstensen, S., Raboni, S.M., Franca, J.C.B., & Teixeira, F. (2019). Standardization of antigenemia and qPCR cut-off values in whole blood for the detection of cytomegalovirus disease in HIV patients. Journal of the Brazilian Society of Tropical Medicine, 52, e20180457.

Cleveland, H., Chau, A., Jeng, Z., Gardner, G., Yoo, R., Zhang, W., & Hernandez, J. (2019). Percutaneous lung biopsy in immunocompromised pediatric patients. Journal of Vascular and Intervention Radiology, 31 (1), P93 – P98.

Collins-McMillen, D., Buehler, J., Peppenelli, M., & Goodrum, F. (2018). Molecular determinants and the regulation of human cytomegalovirus latency and reactivation. Viruses, 10 (8), 444.

Dolskiy, A.A., Grishchenko, I.V., & Yudkin, D.V. (2020). Cell cultures for virology: usability, advantages, and prospects. International Journal of Molecular Sciences, 21 (21), 7978.

Elder, E., Krishna, B., Williamson, J., Aslam, Y., Farahi, N., Wood, A., Romashova, V., Roche, K., Murphy, E., Chilvers, E., Lehner, P.J., Sinclair, J., & Poole, E. (2019). Monocytes latently infected with human cytomegalovirus evade neutrophil killing. iScience, 12, 13 – 26.

Enan, K.A., Rennert, H., El-Eragi, A.M., El-Hussein, A.R.M., & Elkhidir, I.M. (2011). Comparison of real-time PCR to ELISA for the detection of human cytomegalovirus infection in renal transplant patients in the Sudan. Virology Journal, 8, 222.

Fernandes, C., Marques, A., Chasqueira, M.J., Braz, M.C., Ferreira, A.R., Neto, A.S., Mendes, C., Lito, D., Menezes, M., Sousa, M.J., & Paixao, P. (2021). Saliva pools for screening of human cytomegalovirus using real-time PCR. European Journal of Pediatrics, 180, 1067 – 1072.

Fowler, K., Mucha, J., Naumann, M., Lewandowski, W., Kaczanowska, M., Grys, M., Schmidt, E., Natenshon, A., Talarico, C., Buck, P.O., & Diaz-Decaro, J. (2022). A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development. BMC Public Health, 22, 1659.

Gault, E., Michel, Y., Dehee, A., Belabani, C., Nicolas, J., & Garbarg-Chenon, A. (2001). Quantification of human cytomegalovirus DNA by real-time PCR. Journal of Clinical Microbiology, 39 (2), 772 – 775.

Goyal, G., Zinger, T., Warfield, D., & Cao, W. (2022). The trends of immunohistochemistry for tissue-invasive cytomegalovirus in gastrointestinal mucosal biopsies: a large single academic center study. Archives of Pathology & Laboratory Medicine, 146 (3), 360 – 365.

Griffiths, P., Baraniak, I., & Reeves, M. (2015). The pathogenesis of human cytomegalovirus. The Journal of Pathology, 235 (2), 288 – 297.

Griffiths, P., & Reeves, M. (2021). Pathogenesis of human cytomegalovirus in the immunocompromised host. Nature Review Microbiology, 19 (12), 759 – 773.

Haynes, R.J., Kline, M.C., Toman, B., Scott, C., Wallace, P., Butler, J.M., & Holden, M.J. (2013). Standard references material 2366 for measurement of human cytomegalovirus DNA. The Journal of Molecular Diagnostics, 15 (2), 177 – 185.

Hebart, H., Gamer, D., Loeffler, J., Mueller, C., Sinzger, C., Jahn, G., Bader, P., Klingebiel, T., Kanz, L., & Einsele, H. (1998). Evaluation of Murex CMV DNA hybrid capture assay for detection and quantitation of cytomegalovirus infection in patients following allogeneic stem cell transplantation. Journal of Clinical Microbiology, 36 (5), 1333 – 1337.

Hematian, A., Sadeghifard, N., Mohebi, R., Taherikalani, M., Nasrolahi, A., Amraei, M., & Ghafourian, S. (2016). Traditional and modern cell culture in virus diagnosis. Osong Public Health and Research Perspectives, 7 (2), 77 – 82.

Hwang, K., Ahn, J.H., & Nam, J. (2018). Development and validation of multiplex real-time PCR assays for rapid detection of cytomegalovirus, Epstein-Barr virus, and polyomavirus BK in whole blood from transplant candidates. Journal of Microbiology, 56, 593 – 599.

Iijima, S. (2022). Pitfalls in the serological evaluation of maternal cytomegalovirus infection as a potential cause of fetal and neonatal involments: a narrative literature review. Journal of Clinical Medicine, 11 (17), 5006.

Jackson, J.W., & Sparer, T. (2018). There is always another way! Cytomegalovirus’ multifaceted dissemination schemes. Viruses, 10 (7), 383.

Ligozzi, M., Poggi, M., Saletti, M., & Gibellini, D. (2016). Development of a real-time quantitative polymerase chain reaction assay for the detection of congenital human cytomegalovirus infection in urine samples. Molecular and Cellular Probes, 30 (1), 50 - 52.

Lv, Y., Han, F., An Z., Jia, Y., Xuan, L., Gong, L., Zhang, W., Ren, L., Yang, S., Liu, H., & Liu, L. (2020). Cytomegalovirus infection is a risk factor in gastrointestinal cancer: a cross-sectional and meta-analysis study. Intervirology, 63 (1-6), 10 – 16.

Ong, D.S.Y., Chong, G.L.M., Chemaly, R.F., & Cremer, O.L. (2022). Comparative clinical manifestations and immune effects of cytomegalovirus infections following distinct types of immunosuppression. Clinical Microbiology and Infection, 28 (10), 1335 – 1344.

Plotkin, S.A., Wang, D., Oualim, A., Diamond, D.J., Kotton, C.N., Mossman, S., Carfi, A., Anderson, D., & Dormitzer, P.R. (2020). The status of vaccine development against the human cytomegalovirus. The Journal of Infectious Diseases, 221 (S1), S113 – S122.

Razonable, R.R., Inoue, N., Pinninti, S.G., Boppana, S.B., Lazzarotto, T., Gabrielli, L., Simonazzi, G., Pellett, P.E., & Schmid, D.S. (2020). Clinical diagnostic testing for human cytomegalovirus infections. The Journal of Infectious Disease, 221 (S1), S74 – S85.

Revello, M.G., Lilleri, D., Zavattoni, M., Furione, M., Middeldorp, J., & Gerna, G. (2003). Prenatal diagnosis of congenital human cytomegalovirus infection in amniotic fluid by nucleic acid sequence-based amplification assay. Journal of Clinical Microbiology, 41 (4), 1772 – 1774.

Rosa, C.L., & Diamond, D.J. (2012). The immune response to human CMV. Future Virology, 7 (3), 279 – 293.

Ross, S.A., Novak, Z., Pati, S., & Boppana, S.B. (2011). Overview of the diagnosis of cytomegalovirus infection. Infectious Disorders Drug Targets, 11 (5), 466 – 474.

Schäfer, P., Tenschert, W., Gutensohn, K., & Laufs, R. (1997). Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of an antigenemia assay. Journal of Clinical Microbiology 35 (3), 741 - 744.

Schleiss, M.R. (2011). Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis. Infectious Disorders – Drug Targets, 11 (5), 449 – 465.

Schwartz, M., Shnayder, M., Nachshon, A., Arazi, T., Kitsberg, Y., Samia, R.L., Lavi, M., Kuint, R., Tsabari, R., & Stern-Ginossar, N. (2023). Molecular characterization of human cytomegalovirus infection with single-cell transcriptomics. Nature Microbiology, 8, 455 – 468.

Sezgin, E., An, P., & Winkler, C.A. (2019). Host genetics of cytomegalovirus pathogenesis. Frontiers in Genetics, 10, 616.

Stockdale, L., Nash, S., Nalwoga, A., Painter, H., Asiki, G., Fletcher, H., & Newton, R. (2018). Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Uganda cohort. PLoS ONE, 13 (2), e0192086.

Storch, G.A. (2000). Diagnostic virology. Clinical Infectious Diseases, 31 (3), 739 – 751.

Swanson, E.C., & Schleiss, M.R. (2013). Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatric Clinics of North America, 60 (2), 335 – 349.

Touma, J., Liu, Y., Rahbar, A., Pantalone, M.R., Almazan, N.M., Vetvik, K., Soderberg-Naucler, C., Geisler, J., & Sauer, T. (2021). Detection of human cytomegalovirus proteins in paraffin-embedded breast cancer tissue specimens – a novel, automated immunohistochemical staining protocol. Microorganisms, 9 (5), 1059.

Wilkinson, G.W.G., Davison, A.J., Tomasec, P., Fielding, C.A., Aicheler, R., Murrell, I., Seirafian, S., Wang, E.C.Y., Weekes, M., Lehner, P.J., Wilkie, G.S., & Stanton, R.J. (2015). Human cytomegalovirus: taking the strain. Medical Microbiology and Immunology, 204 (3), 273 – 284.

Wills, M.R., Poole, E., Lau, B., Krishna, B., & Sinclair, J.H. (2015). The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies? Cellular & Molecular Immunology, 12, 128 -138.

Zawilinska, B., Szostekm S., Kopec, J., Piatkowska-Jakubas, B., & Kosz-Vnenchak, M. (2016). Multiplex real-time PCR to identify a possible reinfection with different strain of human cytomegalovirus in allogeneic hematopoietic stem cell transplant patients. Acta Biochimica Polonica, 63 (1), 161 – 166.